Is the Precipitation of Anxiety Symptoms Associated with Bolus Doses of Flumazenil a Barrier to Its Use at Low Continuous Doses in Benzodiazepine Withdrawal?

por Gallo, Alexander, MacDonald, Tim, Bennett, Kellie, Basso-Hulse, Gioiamia, Hulse, Gary
Publicado 2022

Immediate Adverse Events Following COVID-19 Vaccination in Australian Pharmacies: A Retrospective Review

por Gallo, Alexander T., Scanlon, Lisa, Clifford, Jade, Patten-Williams, Lawson, Tweedie, Lachlan, Li, Dani, Salter, Sandra M.
Publicado 2022

Long-Term Management of Generalised Anxiety Disorder with Low-Dose Continuous Infusions of Flumazenil: A Case Series

por Gallo, Alexander T., Addis, Stephen, Martyn, Vlad, Ramanathan, Hishani, Wilkerson, Grace K., Hood, Sean D., Stampfer, Hans, Hulse, Gary K.
Publicado 2022

The role of flumazenil in generalised anxiety disorder: a pilot naturalistic open-label study with a focus on treatment resistance

por Gallo, Alexander T, Addis, Stephen, Martyn, Vlad, Ramanathan, Hishani, Wilkerson, Grace K, Bennett, Kellie S, Hood, Sean D, Stampfer, Hans, Hulse, Gary K
Publicado 2023